Therapeutic Asset Ratings
247 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
ce120
Metastatic Malignant Neoplasm
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P1/2
CC
(43)
Crept-618
Metastatic Malignant Neoplasm
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P1/2
CC
(43)
cvl006
Metastatic Malignant Neoplasm
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P1/2
CC
(43)
ibi363
Metastatic Malignant Neoplasm
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P1/2
CC
(43)
Idov-Safetm
Metastatic Malignant Neoplasm
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P1/2
CC
(43)
Immunoglobulin G1 [de-448-lysine], anti-(human epidermal growth factor receptor) (human-mouse monoclonal C225 ?1-chain) fusion protein with peptide linker (GGGGS)2 fusion protein with immunoglobulin anti-(human epidermal growth factor receptor HER3) (human clone HER3.H3 single-chain variable fragment VH-(GGGGS)3-VL), complex with human-mouse monoclonal C225 ?-chain, dimer, 214??,214???,222,222?,228,228?,231,231?-octakis(thioether) with (2S)-N-(carboxymethyl)-2-(3-mercapto-2,5-dioxo-1-pyrrolidinyl)-?-alanylglycylglycyl-L-phenylalanyl-N-[[(1S)-2-[[(1S,9S)-9-ethyl-5-fluoro-2,3,9,10,13,15-hexahydro-9-hydroxy-4-methyl-10,13-dioxo-1H,12H-benzo[de]pyrano[3?,4?:6,7]indolizino[1,2-b]quinolin-1-yl]amino]-1-methyl-2-oxoethoxy]methyl]glycinamide
Metastatic Malignant Neoplasm
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P1/2
CC
(43)
kxv01 tcr lentinvivo
Metastatic Malignant Neoplasm
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P1/2
CC
(43)
lyc001
Metastatic Malignant Neoplasm
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P1/2
CC
(43)
Meta10-Til
Metastatic Malignant Neoplasm
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P1/2
CC
(43)
mt027
Metastatic Malignant Neoplasm
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P1/2
CC
(43)
nk510
Metastatic Malignant Neoplasm
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P1/2
CC
(43)
prg2505
Metastatic Malignant Neoplasm
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P1/2
CC
(43)
qh101
Metastatic Malignant Neoplasm
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P1/2
CC
(43)
t60c
Malignant Solid Tumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P1/2
CC
(43)
Taest1901
Metastatic Malignant Neoplasm
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P1/2
CC
(43)
Tc-N201
Metastatic Malignant Neoplasm
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P1/2
CC
(43)
Vorolanib
Kidney Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P1/2
CC
(43)
Vsv
Metastatic Malignant Neoplasm
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P1/2
CC
(43)
yl-201
Metastatic Malignant Neoplasm
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P1/2
CC
(43)
Ysch-01
Metastatic Malignant Neoplasm
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P1/2
CC
(43)
br101
Plasma Cell Myeloma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P1
CC
(41)
Edb-102
EGFR Gene Mutation
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P1
CC
(41)
nv-001
Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P1
CC
(41)
Ovv-01
Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P1
CC
(41)
bmd006
Advanced Solid Tumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P1/2
CC
(40)
Showing 176 to 200 of 247 assets
Previous
Page 8 of 10
Next